Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Saba Labs
AddedFeb 16, 2024
UpdatedJun 18, 2026
Saba Labs

Saba Labs

Saba Labs: A biotech firm developing cost-effective wound care products to improve patient lives.

HQ
Birmingham, AL, US
Founded
2013
Overview
Compare
Fundraising
Employees

Saba Labs is a biotechnology company focused on developing cost-effective wound care products to improve patient outcomes. Their mission is to address the significant healthcare burden posed by chronic wounds, which affect millions globally due to factors like compromised immune systems, limited mobility, and aging. Saba Labs aims to provide innovative solutions that reduce the financial strain on healthcare systems.

Saba Labs has made notable strides in the biotechnology sector, particularly in wound care. Their products are designed to enhance healing and reduce complications, contributing to a reduction in the annual $25 billion cost burden on the U.S. healthcare system. Their impactful work has positioned them as a key player in the biotech industry.

Saba Labs - Similar Companies

Biowound Solutions logo

Biowound Solutions

WoundForce logo

WoundForce

SAB Biotherapeutics logo

SAB Biotherapeutics

sab.bio

Saber logo

Saber

Newco Wound Care logo

Newco Wound Care

Emunamedica logo

Emunamedica

Biofisica logo

Biofisica

biofisica.com

O2 RegenTech logo

O2 RegenTech

WoundMetrics logo

WoundMetrics

Healogics logo

Healogics

healogics.com

WoundZoom logo

WoundZoom

perceptivesol.com

Regenerex Pharma logo

Regenerex Pharma

RenovoDerm logo

RenovoDerm

The Wound logo

The Wound

woundmdhealth.com

Parable Health logo

Parable Health

parablehealth.com

Saba Labs - Quick Facts

Who are Saba Labs' competitors?

Companies similar to Saba Labs include Biowound Solutions, WoundForce, SAB Biotherapeutics and Saber.

When was Saba Labs founded?

Saba Labs was founded in 2013.

Where is Saba Labs' headquarters located?

Saba Labs' headquarters is located in Birmingham, AL, US.

When was Saba Labs' last funding round?

Saba Labs' most recent funding round was for $2M (USD) in August 2015.

How much has Saba Labs raised to-date?

As of Aug 24, 2015, Saba Labs has raised a total of $2M (USD).

How many employees does Saba Labs have?

Saba Labs has 5 employees as of Feb 5, 2024.

Saba Labs - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Wound Care
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified